Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals

Am Heart J. 2021 Jul:237:1-4. doi: 10.1016/j.ahj.2021.03.010. Epub 2021 Mar 18.

Abstract

Patients with coronavirus disease 2019 (COVID-19) are at heightened risk of venous thromboembolic events (VTE), though there is no data examining when these events occur following a COVID-19 diagnosis. We therefore sought to characterize the incidence, timecourse of events, and outcomes of VTE during the COVID-19 pandemic in a national healthcare system using data from Veterans Affairs Administration.

Publication types

  • Letter

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage*
  • COVID-19 Nucleic Acid Testing
  • COVID-19* / complications
  • COVID-19* / epidemiology
  • COVID-19* / therapy
  • Chemoprevention / methods
  • Chemoprevention / statistics & numerical data
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Incidence
  • Male
  • Outcome Assessment, Health Care
  • Risk Assessment / statistics & numerical data
  • Risk Factors
  • SARS-CoV-2 / isolation & purification
  • United States / epidemiology
  • Venous Thromboembolism* / epidemiology
  • Venous Thromboembolism* / etiology
  • Venous Thromboembolism* / therapy
  • Veterans Health / statistics & numerical data*

Substances

  • Anticoagulants